Retraction Note: Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation
- PMID: 38970111
- PMCID: PMC11225112
- DOI: 10.1186/s12951-024-02692-1
Retraction Note: Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation
Retraction of
-
Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation.J Nanobiotechnology. 2023 Nov 16;21(1):430. doi: 10.1186/s12951-023-02207-4. J Nanobiotechnology. 2023. Retraction in: J Nanobiotechnology. 2024 Jul 5;22(1):397. doi: 10.1186/s12951-024-02692-1. PMID: 37974268 Free PMC article. Retracted.
Similar articles
-
Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation.J Nanobiotechnology. 2023 Nov 16;21(1):430. doi: 10.1186/s12951-023-02207-4. J Nanobiotechnology. 2023. Retraction in: J Nanobiotechnology. 2024 Jul 5;22(1):397. doi: 10.1186/s12951-024-02692-1. PMID: 37974268 Free PMC article. Retracted.
-
Protective Effects of Topical Administration of Laminarin in Oxazolone-Induced Atopic Dermatitis-like Skin Lesions.Mar Drugs. 2022 Oct 26;20(11):669. doi: 10.3390/md20110669. Mar Drugs. 2022. PMID: 36354992 Free PMC article.
-
Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells.J Toxicol Environ Health A. 2021 Nov 17;84(22):922-931. doi: 10.1080/15287394.2021.1955785. Epub 2021 Jul 25. J Toxicol Environ Health A. 2021. PMID: 34304725
-
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.Dermatology. 2017;233(5):333-343. doi: 10.1159/000484407. Epub 2017 Dec 8. Dermatology. 2017. PMID: 29216643 Review.
-
Emerging topical drug delivery approaches for the treatment of Atopic dermatitis.J Cosmet Dermatol. 2022 Feb;21(2):536-549. doi: 10.1111/jocd.14685. Epub 2021 Dec 21. J Cosmet Dermatol. 2022. PMID: 34935274 Review.
Publication types
LinkOut - more resources
Full Text Sources